The Rambus $100 Call Is Nearly a Coin Flip. Watch Royalties, Not Revenue

Rambus trades near $91, roughly half of the $174.10 it touched in January. A stock call now making the rounds says the shares hit $100, on some advertised date. That round number is the least interesting stake in the argument, because everything worth arguing about happened in the gap between a record quarter and the crash that followed it.

The setup is genuinely strange. On July 27, Rambus reported revenue of $207.4 million for the quarter ended June 30 — a record, up 20 percent year over year and above its own $192–198 million guidance. Non-GAAP earnings of $0.77 a share beat the near-$0.72 consensus, and product revenue, the memory-interface chips that connect AI accelerators to memory, rose 22 percent to a record $99.2 million. The stock fell roughly 20 percent within three sessions. When a beat gets sold that hard, the market is not grading the quarter. It is grading the model underneath it.

That model's most fragile wire sits inside the guidance. Rambus splits revenue into three lines: product chips, royalties, and contract work. Royalties — $84.2 million in the June quarter, about 40 percent of sales — are the cheapest revenue the company earns, license income with little manufacturing cost attached. For the quarter now underway, management guided royalties down to $69–$75 million, about 11 to 18 percent below the June result, while guiding product revenue up to $110–$116 million. Total sales are still guided to a fresh record, around $210–216 million. The drift is in the mix: royalties fall from just over 40 percent of revenue to about 34 percent, while product climbs from about 48 percent to 53 percent. Royalties are lumpy — they bounced from about $70 million in the March quarter to $84 million in June — so one guided quarter is not itself a trend. The direction is still the point: the most profitable line is shrinking just as the lower-margin one grows.

That is the "margin pressure" the sell-off was about. GAAP operating margin slipped to 35 percent from 37 percent a year earlier, the non-GAAP version to 45 percent from 46 percent, and trailing net margin has fallen to just under 32 percent from about 35.5 percent. None of this makes Rambus precarious — it carries roughly $825 million in cash — but the market pays about 41 times trailing GAAP earnings and about 13 times sales for roughly 20 percent revenue growth. When the highest-margin line shrinks, earnings can grow slower than revenue, and a 40-times multiple has room to deflate. The share price already encodes part of that story: a 48 percent round trip from the January high is a de-rating, not a dip. For scale, the stock is roughly flat for 2026 and still up about 27 percent over the past year.

Two more weights sit on the bearish side of the scale. In late April, Rambus disclosed a grand-jury subpoena tied to a U.S. criminal antitrust investigation; investor-firm inquiries describe alleged price-fixing of memory-interface chips, including the register clock drivers that anchor the very product line now driving growth. Inventory jumped about 69 percent to $75 million to position for the ramp — normal if the ramp lands, ugly if it slips. And the CEO sold roughly 40,000 shares in March under a pre-arranged trading plan. Each item alone is noise; together they explain why buyers have not handed the stock its January multiple back — and why the record quarter was sold, not chased.

Now put the $100 call between the two crowds. Sell-side analysts carry a median 12-month target around $150, with the low end of the range at $100 and the top near $180, and a consensus rating of Buy. The market is telling them they are wrong by roughly a 60-percent gap. For a stock this volatile — it has ranged from $70.90 to $174.10 within a year — a round $100 by December 31 is close to the coin flip the tape already prices. I would run it just above half: the record keeps printing, a $100 million accelerated buyback launched in August puts a bid under the stock, the probe has not escalated, and the company is pointing to a design win with a Tier 1 U.S. hyperscaler for next-generation HBM. That is the honest scoring on the headline: the $100 call is the low-conviction version of the real disagreement, which is whether Rambus climbs back toward $130-plus over the next twelve months or caps out in a band near where it trades today.

The wager
Outcome	Rambus closes 2026 at or above $100
My line	Roughly 55 percent — the market already prices near a flip
First verdict	Third-quarter report, scheduled for October 26
Kill condition	Q3 royalties land below the guided floor of $69 million, or GAAP operating margin slips again
Settle early	Royalties land near the top of guidance (~$75 million) and product revenue tops its range — then the $100 call becomes a formality and the $130 debate opens

The crowd being tested is the sell side, parked at a ~$150 median with a Buy rating while the stock trades near $91. Its own wobble is visible: Baird cut the shares to Neutral in April, and Evercore trimmed its target from $172 to $160 right after the record quarter. The bulls who bought the July dip now have to prove the margin anxiety is overdone, and the market's verdict so far is that the burden of proof is on them. A right outcome for the wrong reason would not settle the argument either: if $100 is reached only on a news-driven squeeze while royalties keep sliding, that is a bounce with the label of a milestone.

Circle October 26 and watch one number: third-quarter royalty revenue. At the top of the guide, the $100 claim is a milestone on the way to a bigger argument. Below it, the claim is a bounce — and "the stock will trade at $100" quietly becomes "the stock sold the $100 pop." Record revenue already printed this year, and the market sold it. The only clock still running is on the line that is shrinking, not the one that is growing. That is the number to watch when the quarter lands.